跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Berirab P - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Berirab P
Approved
STANDARD
Berirab P
CSL Behring GmbH
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
41f303eab626382d
Company
CSL Behring GmbH
Type
Standard
Approval Details
Approval Id
41f303eab626382d
Drug Approval Philippines Name
Berirab P
Product Name
Berirab P
Registration Number
BR-869
Brand Name
Berirab P
Generic Name
Human Rabies Immunoglobulin
Dosage Form
Solution for Injection (IM)
Dosage Strength
300 IU/2 mL (150 IU/mL)
Manufacturer
CSL Behring GmbH
Importer
Zuellig Pharma Corporation
Distributor
Zuellig Pharma Corporation
Company Detail Path
/organization/csl-behring-gmbh
Issuance Date
27 April 2022
Expiry Date
04 June 2027
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
41f303eab626382d
Type
Standard
Back to Philippines FDA Approvals